Purchase Order 75N91019P00087

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for the Oncomine Comprehensive Manual Combo Kit (catalog A35805) valued at $17,100.00, with an award date of August 6, 2018 and completion date of September 30, 2018. Place of performance is Bethesda, Maryland. The order is priced on a firm fixed price basis with no small business set-aside.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for an Oncomine Comprehensive Manual Combo Kit (catalog A35805) valued at $17,100.00 on August 7, 2018, with completion by September 30, 2018. Place of performance is Bethesda, Maryland. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for an Oncomine Comprehensive Manual Combo Kit valued at $13,295.68 on April 2, 2019, with completion scheduled for May 1, 2019. Place of performance is Carlsbad, California. The order carries firm fixed price and no set-aside designation.</p>

The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,478.46 on May 23, 2019, for drugs and biologicals with an ultimate completion date of June 23, 2019. Work is performed in Grand Island, New York. The order is firm fixed price with no small business set-aside. Life Technologies, a wholly owned subsidiary of Thermo Fisher Scientific, supplies specialized biomedical research instruments, reagents, and consumables to federal agencies as a prime...

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,960 on July 19, 2017, for laboratory supplies, with an ultimate completion date of August 17, 2017. The order is firm fixed price with no set-aside applied. Place of performance is Carlsbad, California. Life Technologies, operating as Thermo Fisher Scientific, manufactures laboratory instrumentation, reagents, and consumables supplied across federal research and diagnostic sectors.</p>

The National Cancer Institute issued a delivery order to Life Technologies Corporation on January 25, 2019, with a ceiling value of $45,930.66 for reagents and consumables supporting Applied Biosystems 3500XL and 3730XL genetic analyzers. Place of performance is Grand Island, NY. The order is priced on a firm fixed price basis and has an ultimate completion date of February 28, 2019. Life Technologies Corporation is a subsidiary of Thermo Fisher Scientific Inc. and a leading provider of...

The National Cancer Institute awarded a purchase order to Life Technologies Corporation on December 7, 2018, for $13,158.00, with ultimate completion on January 16, 2019. No set-aside was used. Performance takes place in Grand Island, New York. The order is for firm fixed-price supply of specialized biomedical research instruments, reagents, or consumables typical of Life Technologies' federal portfolio in genetic analysis, immunoassay, or flow cytometry equipment and related laboratory...

The National Cancer Institute issued a delivery order to Life Technologies Corporation on June 6, 2019, with a ceiling value of $43,354.52 for reagents and consumables supporting Applied Biosystems 3500XL and 3730XL genetic analyzers. Place of performance is Grand Island, NY. The order is firm fixed price with an ultimate completion date of July 6, 2019. Life Technologies Corporation is a subsidiary of Thermo Fisher Scientific Inc. and specializes in biomedical research and genetic analysis...

The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $14,599.10 on July 18, 2017, for laboratory supplies with an ultimate completion date of August 17, 2017. The order is firm fixed price with no set-aside applied. Place of performance is Carlsbad, California. Life Technologies, operating as Thermo Fisher Scientific, supplies laboratory instrumentation, reagents, and consumables to federal research and diagnostic programs across the life sciences...

The National Cancer Institute awarded a $19,905 firm fixed-price purchase order to Life Technologies Corporation (operating as Thermo Fisher Scientific) on December 2, 2024, with an ultimate completion date of November 1, 2025. This contract is part of the FY26 UDO Initiative and was issued without set-aside designation, reflecting open competitive procurement. Life Technologies Corporation, headquartered in Carlsbad, California, is a leading supplier of scientific instrumentation, reagents, and...